
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Shares | 100.950 | 100.950 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 12.082 | 17.767 |
Price to Book | 2.061 | 3.804 |
Price to Sales | 3.602 | 5.020 |
Price to Cash Flow | 8.190 | 15.605 |
Dividend Yield | 0.347 | 0.540 |
5 Years Earnings Growth | 3.109 | 13.106 |
Number of long holdings: 34
Number of short holdings: 26
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Exelixis | US30161Q1040 | 9.96 | 42.77 | +0.23% | |
Ionis Pharma | US4622221004 | 9.64 | 35.25 | +1.41% | |
Biogen | US09062X1037 | 7.89 | 131.99 | +0.11% | |
Crispr Therapeutics | CH0334081137 | 4.98 | 38.40 | +0.95% | |
Jazz Pharma | IE00B4Q5ZN47 | 4.74 | 109.93 | -0.35% | |
Gilead | US3755581036 | 4.71 | 109.26 | -0.06% | |
Biomarin Pharma | US09061G1013 | 4.71 | 56.57 | -0.39% | |
Alnylam | US02043Q1076 | 4.65 | 305.69 | +0.63% | |
Bavarian Nordic | DK0015998017 | 4.50 | 180.4 | +0.50% | |
Denali Therapeutics | US24823R1059 | 4.44 | 14.08 | +1.08% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Selectra J Lamarck Biotech Class B | 57.12M | -12.53 | -11.62 | 0.02 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review